Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  HER2-pulsed type-1 polarized autologous dendritic cell vaccine
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
HER2-Pulsed Type-1 Polarized Autologous Dendritic Cell Vaccine in Treating Patients With Stage I-III HER2 Positive Breast Cancer
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: UPCC 26113, NCI-2014-00878, 818561, NCT02110199, NCT02061423
Start Over